glp 1/gip receptor agonist Schematic illustration of monoagonists, dual agonists and triple Polyagonists Enable Increasingly Effective Treatment
Description
Insulin and incretins are compounds with multiple effects on neurodegenerative processes

These drugs have recently become more comm

Importantly, increasing the endogenous production of GLP-1 by different mechanisms or by increasing the number of intestinal L-cells that tend to produce this hormone may be another effective therapeutic approach to managing T2DM

GLP-1 agonist is a class of medications that are used in type 2 diabetes and obesity
Gut health plus weight loss.
For Indian patients, this is a major development
